Skip to main content

RT-PCR HIV-1 Diagnostic by Abbott and Celera Gets CE Mark

NEW YORK, June 16 (GenomeWeb News) - An Abbott and Celera Diagnostics HIV-1 viral-load test has been awarded the European Union's CE Mark certification, the companies said today in a statement.


The CE Mark allows the companies to sell the PCR-based RealTime HIV-1 assay in the 25 member states of the European Union under the In Vitro Diagnostics Directive, the companies said.


The HIV-1 assay runs on Abbott's m2000 real-time PCR system. Abbot said it is also developing methods for detecting hepatitis C, hepatitis B, chlamydia, and gonorrhea that will run on the m2000 system.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.